Literature DB >> 19883615

KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity.

Diane L Costanzo-Garvey1, Paul T Pfluger, Michele K Dougherty, Jeffery L Stock, Matthew Boehm, Oleg Chaika, Mario R Fernandez, Kurt Fisher, Robert L Kortum, Eun-Gyoung Hong, John Y Jun, Hwi Jin Ko, Aimee Schreiner, Deanna J Volle, Tina Treece, Amy L Swift, Mike Winer, Denise Chen, Min Wu, Lisa R Leon, Andrey S Shaw, John McNeish, Jason K Kim, Deborah K Morrison, Matthias H Tschöp, Robert E Lewis.   

Abstract

Kinase suppressors of Ras 1 and 2 (KSR1 and KSR2) function as molecular scaffolds to potently regulate the MAP kinases ERK1/2 and affect multiple cell fates. Here we show that KSR2 interacts with and modulates the activity of AMPK. KSR2 regulates AMPK-dependent glucose uptake and fatty acid oxidation in mouse embryonic fibroblasts and glycolysis in a neuronal cell line. Disruption of KSR2 in vivo impairs AMPK-regulated processes affecting fatty acid oxidation and thermogenesis to cause obesity. Despite their increased adiposity, ksr2(-/-) mice are hypophagic and hyperactive but expend less energy than wild-type mice. In addition, hyperinsulinemic-euglycemic clamp studies reveal that ksr2(-/-) mice are profoundly insulin resistant. The expression of genes mediating oxidative phosphorylation is also downregulated in the adipose tissue of ksr2(-/-) mice. These data demonstrate that ksr2(-/-) mice are highly efficient in conserving energy, revealing a novel role for KSR2 in AMPK-mediated regulation of energy metabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19883615      PMCID: PMC2773684          DOI: 10.1016/j.cmet.2009.09.010

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  43 in total

1.  C. elegans ksr-1 and ksr-2 have both unique and redundant functions and are required for MPK-1 ERK phosphorylation.

Authors:  Mitsue Ohmachi; Christian E Rocheleau; Diane Church; Eric Lambie; Tim Schedl; Meera V Sundaram
Journal:  Curr Biol       Date:  2002-03-05       Impact factor: 10.834

Review 2.  Regulation of MAP kinase signaling modules by scaffold proteins in mammals.

Authors:  Deborah K Morrison; Roger J Davis
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

3.  The molecular scaffold KSR1 regulates the proliferative and oncogenic potential of cells.

Authors:  Robert L Kortum; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

4.  Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo.

Authors:  AnhCo Nguyen; W Richard Burack; Jeffrey L Stock; Robert Kortum; Oleg V Chaika; Maryam Afkarian; William J Muller; Kenneth M Murphy; Deborah K Morrison; Robert E Lewis; John McNeish; Andrey S Shaw
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

5.  Identification of a novel human kinase supporter of Ras (hKSR-2) that functions as a negative regulator of Cot (Tpl2) signaling.

Authors:  Padma L Channavajhala; Leeying Wu; John W Cuozzo; J Perry Hall; Wei Liu; Lih-Ling Lin; Yuhua Zhang
Journal:  J Biol Chem       Date:  2003-09-15       Impact factor: 5.157

6.  Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit.

Authors:  Josep A Villena; Benoit Viollet; Fabrizzio Andreelli; Axel Kahn; Sophie Vaulont; Hei Sook Sul
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

7.  Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites.

Authors:  Stéphane Ory; Ming Zhou; Thomas P Conrads; Timothy D Veenstra; Deborah K Morrison
Journal:  Curr Biol       Date:  2003-08-19       Impact factor: 10.834

Review 8.  Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity.

Authors:  Neil B Ruderman; Asish K Saha; Edward W Kraegen
Journal:  Endocrinology       Date:  2003-09-18       Impact factor: 4.736

9.  The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.

Authors:  Benoit Viollet; Fabrizio Andreelli; Sebastian B Jørgensen; Christophe Perrin; Alain Geloen; Daisy Flamez; James Mu; Claudia Lenzner; Olivier Baud; Myriam Bennoun; Emmanuel Gomas; Gaël Nicolas; Jørgen F P Wojtaszewski; Axel Kahn; David Carling; Frans C Schuit; Morris J Birnbaum; Erik A Richter; Rémy Burcelin; Sophie Vaulont
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

10.  PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

Authors:  Vamsi K Mootha; Cecilia M Lindgren; Karl-Fredrik Eriksson; Aravind Subramanian; Smita Sihag; Joseph Lehar; Pere Puigserver; Emma Carlsson; Martin Ridderstråle; Esa Laurila; Nicholas Houstis; Mark J Daly; Nick Patterson; Jill P Mesirov; Todd R Golub; Pablo Tamayo; Bruce Spiegelman; Eric S Lander; Joel N Hirschhorn; David Altshuler; Leif C Groop
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

View more
  76 in total

1.  Kinase suppressor of ras 1 (KSR1) regulates PGC1α and estrogen-related receptor α to promote oncogenic Ras-dependent anchorage-independent growth.

Authors:  Kurt W Fisher; Binita Das; Robert L Kortum; Oleg V Chaika; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

Review 2.  Signal control through Raf: in sickness and in health.

Authors:  Jihan K Osborne; Elma Zaganjor; Melanie H Cobb
Journal:  Cell Res       Date:  2011-12-06       Impact factor: 25.617

Review 3.  Mechanistic principles of RAF kinase signaling.

Authors:  Christian M Udell; Thanashan Rajakulendran; Frank Sicheri; Marc Therrien
Journal:  Cell Mol Life Sci       Date:  2010-09-06       Impact factor: 9.261

Review 4.  Functional proteomics to dissect tyrosine kinase signalling pathways in cancer.

Authors:  Walter Kolch; Andrew Pitt
Journal:  Nat Rev Cancer       Date:  2010-08-19       Impact factor: 60.716

5.  High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice.

Authors:  Maarit Lehti; Elizabeth Donelan; William Abplanalp; Omar Al-Massadi; Kirk M Habegger; Jon Weber; Chandler Ress; Johannes Mansfeld; Sonal Somvanshi; Chitrang Trivedi; Michaela Keuper; Teja Ograjsek; Cynthia Striese; Sebastian Cucuruz; Paul T Pfluger; Radhakrishna Krishna; Scott M Gordon; R A Gangani D Silva; Serge Luquet; Julien Castel; Sarah Martinez; David D'Alessio; W Sean Davidson; Susanna M Hofmann
Journal:  Circulation       Date:  2013-10-29       Impact factor: 29.690

Review 6.  New targets to treat obesity and the metabolic syndrome.

Authors:  Kathleen A Martin; Mitra V Mani; Arya Mani
Journal:  Eur J Pharmacol       Date:  2015-05-19       Impact factor: 4.432

Review 7.  Regulation of RAF protein kinases in ERK signalling.

Authors:  Hugo Lavoie; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05       Impact factor: 94.444

8.  Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation.

Authors:  Che-Hung Shen; Ping Yuan; Rolando Perez-Lorenzo; Yaqing Zhang; Sze Xian Lee; Yang Ou; John M Asara; Lewis C Cantley; Bin Zheng
Journal:  Mol Cell       Date:  2013-10-03       Impact factor: 17.970

Review 9.  Hypothalamic AMPK: a canonical regulator of whole-body energy balance.

Authors:  Miguel López; Rubén Nogueiras; Manuel Tena-Sempere; Carlos Diéguez
Journal:  Nat Rev Endocrinol       Date:  2016-05-20       Impact factor: 43.330

10.  Inflammation and insulin resistance: an old story with new ideas.

Authors:  Jason K Kim
Journal:  Korean Diabetes J       Date:  2010-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.